ATE449084T1 - Derivate von heterocyclen und arzneistoffe - Google Patents

Derivate von heterocyclen und arzneistoffe

Info

Publication number
ATE449084T1
ATE449084T1 AT01917752T AT01917752T ATE449084T1 AT E449084 T1 ATE449084 T1 AT E449084T1 AT 01917752 T AT01917752 T AT 01917752T AT 01917752 T AT01917752 T AT 01917752T AT E449084 T1 ATE449084 T1 AT E449084T1
Authority
AT
Austria
Prior art keywords
alkyl
different
same
group
hydrogen atom
Prior art date
Application number
AT01917752T
Other languages
German (de)
English (en)
Inventor
Masahiko Okano
Kazuya Copo Mori
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE449084T1 publication Critical patent/ATE449084T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01917752T 2000-03-31 2001-03-30 Derivate von heterocyclen und arzneistoffe ATE449084T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000098874 2000-03-31
JP2000336464 2000-11-02
PCT/JP2001/002822 WO2001072710A1 (en) 2000-03-31 2001-03-30 Heterocycle derivatives and drugs

Publications (1)

Publication Number Publication Date
ATE449084T1 true ATE449084T1 (de) 2009-12-15

Family

ID=26589216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917752T ATE449084T1 (de) 2000-03-31 2001-03-30 Derivate von heterocyclen und arzneistoffe

Country Status (10)

Country Link
US (1) US6794389B2 (enExample)
EP (1) EP1306372B1 (enExample)
KR (1) KR20020083533A (enExample)
CN (1) CN1242993C (enExample)
AT (1) ATE449084T1 (enExample)
AU (1) AU2001244688A1 (enExample)
CA (1) CA2403605A1 (enExample)
DE (1) DE60140545D1 (enExample)
RU (1) RU2268260C2 (enExample)
WO (1) WO2001072710A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040044204A1 (en) * 2000-09-20 2004-03-04 Werner Mederski 4-amino-quinazolines
US7220751B2 (en) 2000-11-02 2007-05-22 Nippon Shinyaku Co., Ltd. Quinazoline derivatives and drugs
KR20030085005A (ko) * 2001-03-19 2003-11-01 니뽄 신야쿠 가부시키가이샤 진양제
US6907295B2 (en) * 2001-08-31 2005-06-14 Biocontrol Medical Ltd. Electrode assembly for nerve control
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
EP1500652A4 (en) * 2002-04-26 2006-05-03 Nippon Shinyaku Co Ltd DERIVATIVE AND MEDICINAL PRODUCT OF QUINAZOLINE
JP4805234B2 (ja) * 2002-12-16 2011-11-02 キッセイ薬品工業株式会社 経口固形医薬
CA2531327A1 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. Compounds and therapeutical use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2005070929A1 (en) * 2004-01-23 2005-08-04 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
CA2624141C (en) * 2005-10-03 2014-07-08 Nippon Shinyaku Co., Ltd. Quinazoline derivative and pharmaceutical
RU2314295C2 (ru) * 2006-03-01 2008-01-10 Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Южный Федеральный Университет" 2-гетарилзамещенные 1,3-трополона, способ их получения (варианты) и фармацевтическая композиция антимикробного действия
EP2481735A1 (en) * 2007-05-09 2012-08-01 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
EP2017294A1 (de) 2007-07-16 2009-01-21 Sika Technology AG Hitzehärtender Schaum
CN102325755B (zh) 2008-12-30 2015-07-01 艾科尔公司 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物
WO2012027495A1 (en) 2010-08-27 2012-03-01 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
DK2799431T3 (en) 2011-12-28 2018-03-26 Fujifilm Corp Hitherto unknown nicotinamide derivatives or salts thereof
WO2021212010A2 (en) 2020-04-17 2021-10-21 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections
WO2024258849A2 (en) 2023-06-13 2024-12-19 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753981A (en) * 1970-07-15 1973-08-21 Squibb & Sons Inc 4-amino-2-styrylquinazoline compounds
PT100905A (pt) 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
WO1997020821A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl derivatives
WO1998017267A1 (en) 1996-10-23 1998-04-30 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
CA2226058C (en) 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
AR012634A1 (es) 1997-05-02 2000-11-08 Sugen Inc Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
CA2291094C (en) 1997-05-30 2008-02-26 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivative
WO1999009986A1 (en) * 1997-08-22 1999-03-04 Kyowa Hakko Kogyo Co., Ltd. 4-aminoquinazoline derivatives
NZ507760A (en) * 1998-03-26 2002-10-25 Japan Tobacco Inc Amide derivatives and nociceptin antagonists
KR20030085005A (ko) 2001-03-19 2003-11-01 니뽄 신야쿠 가부시키가이샤 진양제

Also Published As

Publication number Publication date
DE60140545D1 (enExample) 2009-12-31
US6794389B2 (en) 2004-09-21
KR20020083533A (ko) 2002-11-02
WO2001072710A1 (en) 2001-10-04
RU2268260C2 (ru) 2006-01-20
CN1242993C (zh) 2006-02-22
AU2001244688A1 (en) 2001-10-08
CA2403605A1 (en) 2002-09-18
EP1306372B1 (en) 2009-11-18
RU2002129100A (ru) 2004-02-27
CN1422255A (zh) 2003-06-04
US20030119855A1 (en) 2003-06-26
EP1306372A4 (en) 2004-03-17
EP1306372A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
EP1306372A4 (en) DERIVATIVES OF HETEROCYCLES AND ACTIVE SUBSTANCES
DK1357111T3 (da) 2-pyridonderivater med affinitet for cannabinoid type 2-receptor
DK0567982T3 (da) Azolforbindelser, deres fremstilling og anvendelse
ATE80617T1 (de) Mittel zur ortsspezifischen alkylierung.
EP1176959A4 (en) NEW PROLIN COMPOUNDS AS A MICROBICIDE AGENT
ATE232531T1 (de) Heterobizyklische derivate
NO983970D0 (no) Tricykliske forbindelser, deres fremstilling og anvendelse
DE69524246D1 (de) 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten
TR25360A (tr) HERBISID ÖZELLIKTE KARBOKSAMID TüREVLERI.
DE69304883D1 (de) Xanthin Derivate
DK0535231T3 (da) Pyrimidinnucleosid-derivater
DE60132484D1 (de) Chinazolinderivate und -arzneimittel
ATE172452T1 (de) Bicyclische stichstoff enthaltende derivate als prolyl-endopeptidase inhibitoren
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
MY119238A (en) 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
PT88003A (pt) Processo para a preparacao de di-hidropiridinas condensadas com um anel carbociclico ou heterociclico
EP0882721A4 (en) SIALIC ACIDS 2,7-DIDEOXY-7-FLUORO- 2, 3-DIDEHYDRO A QUADRUPLE SUBSTITUTION
DE69824722D1 (de) Benzimidazole derivate
ATE196137T1 (de) Thiazolin-derivate
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
EA200400770A1 (ru) Производные 5-(пиридин-3-ил)-1-азабицикло[3.2.1]октана, их получение и применение в терапии
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
DE69529807D1 (de) Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren
FI882021A0 (fi) Anilidherbicider.
IT1205114B (it) 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties